Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.49B | 14.54B | 29.70B | 23.86B | 27.34B | Gross Profit |
20.49B | 14.54B | 29.70B | 23.86B | 27.34B | EBIT |
10.86B | 5.93B | 4.27B | 6.51B | 3.36B | EBITDA |
0.00 | 0.00 | 5.82B | 0.00 | 0.00 | Net Income Common Stockholders |
4.61B | 4.12B | 4.36B | 5.27B | 2.82B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
41.30B | 91.47B | 112.15B | 120.64B | 113.68B | Total Assets |
877.76B | 860.36B | 882.83B | 907.47B | 884.42B | Total Debt |
23.48B | 52.52B | 51.16B | 58.95B | 61.41B | Net Debt |
-17.83B | -89.59B | -60.99B | -61.69B | -52.27B | Total Liabilities |
772.02B | 752.03B | 786.57B | 805.39B | 784.59B | Stockholders Equity |
105.46B | 97.97B | 95.99B | 101.78B | 98.89B |
Cash Flow | Free Cash Flow | |||
-8.28B | -17.60B | 9.86B | 1.71B | 13.91B | Operating Cash Flow |
-7.74B | -16.92B | 10.41B | 2.32B | 14.51B | Investing Cash Flow |
-318.00M | -511.00M | 3.17B | -42.20B | -5.67B | Financing Cash Flow |
4.94B | -1.74B | -30.04B | 43.10B | 5.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $5.09B | 7.35 | 12.85% | 3.83% | 13.85% | 2.43% | |
77 Outperform | $4.95B | 10.86 | 7.40% | 3.48% | 10.34% | 2.54% | |
76 Outperform | $3.47B | 8.95 | 15.46% | 36.17% | -48.81% | 0.18% | |
76 Outperform | $4.18B | 11.25 | 10.19% | 1.32% | 7.16% | 31.69% | |
75 Outperform | $3.89B | 9.53 | 15.20% | 2.24% | 4.24% | 0.38% | |
64 Neutral | $12.73B | 9.92 | 7.90% | 78.88% | 12.06% | -7.95% | |
63 Neutral | $3.84B | 7.47 | 4.04% | 6.72% | 2.10% | 15.73% |